Quick Answer
Bausch Health Companies Inc. reported Long-Term Debt of $20.59 billion for fiscal year 2025.
Bausch Health Companies Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $20.59B | +8.7% |
| 2024 | $18.94B | -13.7% |
| 2023 | $21.94B | +7.9% |
| 2022 | $20.33B | -10.2% |
| 2021 | $22.65B | -5.3% |
| 2020 | $23.93B | -3.0% |
| 2019 | $24.66B | +2.4% |
| 2018 | $24.08B | -4.6% |
| 2017 | $25.23B | -15.4% |
| 2016 | $29.84B | -1.4% |
| 2015 | $30.27B | +98.7% |
| 2014 | $15.23B | -11.3% |
| 2013 | $17.16B | +62.9% |
| 2012 | $10.54B | +61.1% |
| 2011 | $6.54B | +88.0% |
| 2010 | $3.48B | +1007.9% |
| 2009 | $313.98M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.46B | -2.8% | -1.9% |
| June 30, 2025 | $20.86B | -1.6% | -1.7% |
| March 31, 2025 | $21.23B | -1.4% | +12.1% |
| December 31, 2024 | $18.94B | -13.7% | -10.0% |
| September 30, 2024 | $21.05B | -3.8% | -0.7% |
| June 30, 2024 | $21.21B | +5.5% | -1.5% |
| March 31, 2024 | $21.54B | +6.6% | -1.8% |
| December 31, 2023 | $21.94B | +7.9% | +0.2% |
- Bausch Health Companies Inc. showed an increase of +8.7% in Long-Term Debt compared to the prior fiscal year.
- Over the 2009–2025 period, Bausch Health Companies Inc.’s long-term debt has grown by 6458.5% (from $313.98 million to $20.59 billion).
- The most recent figure is from Bausch Health Companies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: